Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1988 Nov;78(11):1479–1481. doi: 10.2105/ajph.78.11.1479

Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86.

E Hemminki 1, D L Kennedy 1, C Baum 1, S M McKinlay 1
PMCID: PMC1350246  PMID: 3177727

Abstract

This paper describes changes in the prescribing of noncontraceptive estrogens and progestins, using data from pharmaceutical marketing surveys. The number of estrogen prescriptions decreased from 1975 to 1980, and then increased through 1986. Progestin use has increased since 1982; concomitant use of estrogens and progestins increased over time and was common in 1986. The trends suggest that the use of estrogens, particularly the combined use of estrogens and progestins, will continue to increase.

Full text

PDF
1479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett-Connor E. Postmenopausal estrogens--current prescribing patterns of San Diego gynecologists. West J Med. 1986 May;144(5):620–621. [PMC free article] [PubMed] [Google Scholar]
  2. Buring J. E., Bain C. J., Ehrmann R. L. Conjugated estrogen use and risk of endometrial cancer. Am J Epidemiol. 1986 Sep;124(3):434–441. doi: 10.1093/oxfordjournals.aje.a114414. [DOI] [PubMed] [Google Scholar]
  3. Bush T. L., Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 1985;7:89–104. [PubMed] [Google Scholar]
  4. Kennedy D. L., Baum C., Forbes M. B. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol. 1985 Mar;65(3):441–446. [PubMed] [Google Scholar]
  5. Pasley B. H., Standfast S. J., Katz S. H. Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981. Public Health Rep. 1984 Jul-Aug;99(4):424–429. [PMC free article] [PubMed] [Google Scholar]
  6. Stampfer M. J., Willett W. C., Colditz G. A., Rosner B., Speizer F. E., Hennekens C. H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985 Oct 24;313(17):1044–1049. doi: 10.1056/NEJM198510243131703. [DOI] [PubMed] [Google Scholar]
  7. Strom B. L., Melmon K. L., Miettinen O. S. Post-marketing studies of drug efficacy: why? Am J Med. 1985 Mar;78(3):475–480. doi: 10.1016/0002-9343(85)90341-9. [DOI] [PubMed] [Google Scholar]
  8. Wilson P. W., Garrison R. J., Castelli W. P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med. 1985 Oct 24;313(17):1038–1043. doi: 10.1056/NEJM198510243131702. [DOI] [PubMed] [Google Scholar]
  9. Wingo P. A., Layde P. M., Lee N. C., Rubin G., Ory H. W. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA. 1987 Jan 9;257(2):209–215. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES